Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
177.93
+0.73 (0.41%)
At close: Mar 28, 2024, 4:00 PM
182.15
+4.22 (2.37%)
After-hours: Mar 28, 2024, 7:15 PM EDT

Krystal Biotech Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Krystal Biotech stock have an average target of 159.64, with a low estimate of 139 and a high estimate of 195. The average target predicts a decrease of -10.28% from the current stock price of 177.93.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $139 $159.64 $155 $195
Change -21.88% -10.28% -12.89% +9.59%
* Price targets were last updated on Feb 27, 2024.

Analyst Ratings

The average analyst rating for KRYS stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 89991010
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 91010101111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$160$195
Strong Buy Maintains $160$195 +9.59% Feb 27, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$130$175
Strong Buy Maintains $130$175 -1.65% Feb 27, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$160$180
Buy Maintains $160$180 +1.16% Dec 13, 2023
Goldman Sachs
Goldman Sachs
Strong Buy
Initiates
$160
Strong Buy Initiates $160 -10.08% Nov 20, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$160
Buy Reiterates $160 -10.08% Nov 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
249.83M
from 50.70M
Increased by 392.77%
Revenue Next Year
424.64M
from 249.83M
Increased by 69.97%
EPS This Year
1.33
from 0.39
Increased by 241.83%
EPS Next Year
4.11
from 1.33
Increased by 208.23%
Year 2019202020212022202320242025202620272028
Revenue
----50.70M249.83M424.64M617.67M639.16M792.85M
Revenue Growth
-----392.77%69.97%45.46%3.48%24.05%
EPS
-1.20-1.71-3.13-5.490.391.334.118.719.0713.23
EPS Growth
-----241.83%208.23%111.90%4.20%45.87%
No. Analysts -----1312864
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 331.2M 603.8M 811.7M 826.6M 967.1M
Avg 249.8M 424.6M 617.7M 639.2M 792.9M
Low 172.3M 246.0M 472.5M 512.5M 595.8M

Revenue Growth

Revenue Growth 20242025202620272028
High
553.2%
141.7%
91.1%
33.8%
51.3%
Avg
392.8%
70.0%
45.5%
3.5%
24.0%
Low
239.8%
-1.5%
11.3%
-17.0%
-6.8%

EPS Forecast

EPS 20242025202620272028
High 4.03 8.16 13.90 12.78 14.86
Avg 1.33 4.11 8.71 9.07 13.23
Low -1.17 0.33 2.98 3.76 11.56

EPS Growth

EPS Growth 20242025202620272028
High
933.8%
512.0%
238.3%
46.8%
63.8%
Avg
241.8%
208.2%
111.9%
4.2%
45.9%
Low -
-75.0%
-27.5%
-56.8%
27.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.